APO-B SIGNAL PEPTIDE INSERTION DELETION POLYMORPHISM IS INVOLVED IN POSTPRANDIAL LIPOPARTICLES RESPONSES

被引:18
作者
REGISBAILLY, A [1 ]
FOURNIER, B [1 ]
STEINMETZ, J [1 ]
GUEGUEN, R [1 ]
SIEST, G [1 ]
VISVIKIS, S [1 ]
机构
[1] CTR MED PREVENT,CNRS,URA 597,F-54501 VANDOEUVRE NANCY,FRANCE
关键词
POSTPRANDIAL; LIPOPROTEIN PARTICLES; GENETIC POLYMORPHISMS; APO B; APO E;
D O I
10.1016/0021-9150(95)05589-O
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The changes in postprandial concentrations of five lipoparticles (LpC-III, LpC-III:B, LpC-IIInoB, LpA-I and LpA-I:A-II) were studied on 144 apparently healthy (71 male and 73 female) subjects during the 4 h following the ingestion of a 1.260 kJ milkshake. The influence of apo B signal peptide polymorphism, apo E polymorphism, and other factors including age, gender, BMI, tobacco and alcohol consumption on the postprandial responses of lipoparticles was investigated. Ape-A-I-containing lipoparticles were not influenced during the 4 h following the test meal except for LpA-I:A-II, which decreased in women. LpA-I:A-II is the only particle that showed a gender-dependent change in postprandial concentration. Apo-CIII-containing lipoparticles showed significant postprandial variations. Particles containing both apo B and apo C-III (total LpC-III and LpC-III:B), mainly present in VLDL fraction, had significantly different postprandial responses among the genotypes of the apo B signal peptide polymorphism. Homozygotes for Dei allele showed a decrease of LpC-III:B concentrations over the 4 h, whereas Ins/Ins homozygotes and Ins/Del heterozygotes had a peak in concentration at 2 h. The apo B signal peptide polymorphism explained 2.3% of the variance of LpCIII:B, whereas apo E polymorphism did not influence the postprandial concentrations of any lipoparticles.
引用
收藏
页码:23 / 34
页数:12
相关论文
共 59 条
[1]  
AALTOSETALA K, 1989, HUM GENET, V82, P305
[2]   STUDIES ON COMPOSITION AND STRUCTURE OF PLASMA LIPOPROTEINS DISTRIBUTION OF LIPOPROTEIN FAMILIES IN MAJOR DENSITY CLASSES OF NORMAL HUMAN PLASMA LIPOPROTEINS [J].
ALAUPOVI.P ;
LEE, DM ;
MCCONATH.WJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (04) :689-&
[3]  
ALSAYED N, 1990, CLIN CHEM, V36, P2047
[4]   CONCENTRATIONS OF APOLIPOPROTEINS-B, APOLIPOPROTEINS-C-I, APOLIPOPROTEINS-C-II, APOLIPOPROTEINS-C-III, APOLIPOPROTEINS-E AND LIPIDS IN SERUM AND SERUM-LIPOPROTEINS OF NORMAL SUBJECTS DURING ALIMENTARY LIPEMIA [J].
ANNUZZI, G ;
HOLMQUIST, L ;
CARLSON, LA .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1989, 49 (01) :73-81
[5]   SUBPOPULATIONS OF APOLIPOPROTEIN-A-I IN HUMAN HIGH-DENSITY LIPOPROTEINS THEIR METABOLIC PROPERTIES AND RESPONSE TO DRUG-THERAPY [J].
ATMEH, RF ;
SHEPHERD, J ;
PACKARD, CJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 751 (02) :175-188
[6]   POSTPRANDIAL EXCHANGE OF APOLIPOPROTEIN C-III BETWEEN PLASMA-LIPOPROTEINS [J].
BARR, SI ;
KOTTKE, BA ;
MAO, SJT .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (02) :191-198
[7]  
BOERWINKLE E, 1991, AM J HUM GENET, V49, P1145
[8]   SIGNAL PEPTIDE LENGTH VARIATION IN HUMAN APOLIPOPROTEIN-B GENE - MOLECULAR CHARACTERISTICS AND ASSOCIATION WITH PLASMA-GLUCOSE LEVELS [J].
BOERWINKLE, E ;
CHEN, SH ;
VISVIKIS, S ;
HANIS, CL ;
SIEST, G ;
CHAN, L .
DIABETES, 1991, 40 (11) :1539-1544
[9]  
BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
[10]  
BOERWINKLE E, 1994, AM J HUM GENET, V54, P341